On August 15, North Dakota regulators granted ETP’s request to postpone hearings on its alleged violation of state rules with its Dakota Access Pipeline.
The British Columbian government recently announced its intention to join the legal fight against Kinder Morgan’s Trans-Mountain Pipeline Expansion project.
Pipeline projects in the US have attracted a lot of attention in recent years.
Recently, NextEra Energy’s solid earnings growth was reflected in its market performance. NextEra Energy stock has outperformed broader utilities.
NextEra Energy has increased its per share dividends for the last 11 consecutive years. Its relatively lower payout ratio at 55% might concern investors.
NextEra Energy (NEE), the largest component of the S&P 500 Utilities Index (XLU), had one of the highest dividend growths in recent years.
NextEra Energy declared a dividend of $0.98 per share on July 28, 2017. It has an ex-dividend date of August 23, which will be paid on September 15, 2017.
Seadrill (SDRL) plans to release its 2Q17 results on August 24. In 1Q17, Seadrill’s revenues totaled $569 million, nearly 14.6% lower than its 4Q16 revenues of $667 million.
As of August 17, 2017, International Flavors and Fragrances traded at a one-year forward PE (price-to-earnings) multiple of 22.20x.
International Flavors and Fragrances continues to work towards its 2020 vision of increasing its revenue by $500 million by way of acquisitions.
In the past five years, IFF’s dividend yield has fallen from 1.9% to its present 1.5%.
International Flavors and Fragrances (IFF) will pay a quarterly dividend of $0.69 per share on October 6, 2017.
As of July 31, 2017, California Resources’ (CRC) total shares shorted (or short interest) stood at ~16.3 million.
For 2Q17, California Resources (CRC) reported operating cash flow of -$13.0 million, which is much lower than analysts’ expectation of $79.0 million.
For 2Q17, California Resources (CRC) reported total production of 129 Mboepd, which is below the midpoint production guidance of 128 Mboepd to 133 Mboepd.
For 2Q17, California Resources (CRC) reported revenues of ~$516.0 million, which was much higher than Wall Street analysts’ consensus of ~$482.0 million.
California Resources (CRC) announced its 2Q17 earnings on August 3, 2017. According to its press release, it was a worse-than-expected loss of ~$78.0 million.
In July 2017, the FDA accepted Bristol-Myers Squibb’s supplemental New Drug Application (or sNDA) for expanding the indication of Sprycel.
In 2Q17, Orencia contributed around 13% of Bristol-Myers Squibb’s net revenues.
In the Phase 3 CheckMate-214 trial, 41.6% patients on Opdivo and Yervoy combination therapy achieved the objective response rate (or ORR) compared to 26.5% patients who were on sunitinib.